A total of 72 patients with lung adenocarcinoma (30 males and 42 females; age 55.9 ± 11.6 years old) who underwent DESCT scanning and EGFR and KRAS testing were included in this study. The gene discussed is KRAS; the disease is lung adenocarcinoma.